Deutsche Bank Aktiengesellschaft Boosts Lam Research (NASDAQ:LRCX) Price Target to $195.00

Lam Research (NASDAQ:LRCX) had its target price upped by analysts at Deutsche Bank Aktiengesellschaft from $160.00 to $195.00 in a research report issued on Friday,MarketScreener reports. The firm currently has a “buy” rating on the semiconductor company’s stock. Deutsche Bank Aktiengesellschaft’s target price suggests a potential upside of 17.47% from the company’s current price.

A number of other research firms also recently weighed in on LRCX. B. Riley lifted their price target on Lam Research from $180.00 to $195.00 and gave the company a “buy” rating in a research note on Thursday. Evercore ISI boosted their price target on Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a research note on Thursday, October 23rd. Barclays set a $142.00 price objective on Lam Research and gave the company an “equal weight” rating in a research note on Monday, October 20th. Mizuho raised their price target on Lam Research from $170.00 to $200.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Oppenheimer set a $200.00 price objective on shares of Lam Research and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Twenty-six investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, Lam Research has a consensus rating of “Moderate Buy” and an average price target of $160.37.

Lam Research Price Performance

Shares of LRCX opened at $166.00 on Friday. The stock has a market cap of $208.50 billion, a PE ratio of 36.56, a price-to-earnings-growth ratio of 1.59 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.21 and a quick ratio of 1.60. Lam Research has a 1-year low of $56.32 and a 1-year high of $169.69. The firm has a fifty day moving average price of $154.01 and a 200 day moving average price of $122.18.

Lam Research (NASDAQ:LRCX) last announced its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. During the same period in the previous year, the company posted $0.86 EPS. The company’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts anticipate that Lam Research will post 3.71 EPS for the current year.

Insiders Place Their Bets

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the sale, the director directly owned 1,652 shares in the company, valued at $264,303.48. The trade was a 44.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Vahid Vahedi sold 52,190 shares of the company’s stock in a transaction that occurred on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares in the company, valued at $34,870,428.30. The trade was a 17.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 102,608 shares of company stock worth $14,916,496. Company insiders own 0.31% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of LRCX. IMG Wealth Management Inc. bought a new stake in shares of Lam Research in the 2nd quarter worth approximately $26,000. Stance Capital LLC bought a new position in shares of Lam Research in the third quarter valued at approximately $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research during the second quarter valued at approximately $27,000. Triumph Capital Management bought a new stake in Lam Research during the third quarter worth approximately $27,000. Finally, Strategic Wealth Investment Group LLC acquired a new stake in Lam Research in the second quarter worth approximately $29,000. 84.61% of the stock is owned by institutional investors and hedge funds.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.